Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03964337
Title Immediate Prostatectomy vs. Cabozantinib Followed by Prostatectomy in Men With High-Risk Prostate Cancer (SPARC)
Acronym SPARC
Recruitment Terminated
Gender male
Phase Phase II
Variant Requirements No
Sponsors Duke University
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.